Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,143 | 72,184 | 43,446 | 69,313 | 43,836 |
| Marketable Securities | 369,107 | 350,905 | 120,591 | 106,770 | 150,586 |
| Receivables | 172 | 197 | 496 | 1,828 | 1,802 |
| TOTAL | $410,839 | $426,555 | $167,606 | $181,499 | $197,843 |
| Non-Current Assets | |||||
| PPE Net | 3,551 | 3,342 | 3,496 | 3,747 | 3,815 |
| Intangibles | 27,190 | 27,190 | 30,690 | 30,690 | 30,690 |
| Other Non-Current Assets | 3,074 | 3,114 | 2,759 | 3,129 | 3,490 |
| TOTAL | $33,815 | $33,646 | $36,945 | $37,566 | $37,995 |
| Total Assets | $444,654 | $460,201 | $204,551 | $219,065 | $235,838 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,721 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,228 | 836 | 685 | 997 | 1,048 |
| Accrued Expenses | 12,000 | 10,253 | 7,851 | 7,023 | 8,459 |
| Other current liabilities | 1,554 | N/A | 4,621 | 7,585 | 3,372 |
| TOTAL | $16,528 | $14,176 | $14,488 | $16,977 | $14,206 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,296 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 7,354 | 9,313 | 7,781 | 7,922 | 12,275 |
| TOTAL | $8,650 | $9,313 | $7,781 | $7,922 | $12,275 |
| Total Liabilities | $25,178 | $23,489 | $22,269 | $24,899 | $26,481 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,735 | 46,664 | 46,482 | 39,615 | 39,615 |
| Common Shares | 47 | 47 | 40 | 40 | 40 |
| Retained earnings | -1,143,607 | -1,123,459 | -1,103,007 | -1,089,634 | -1,073,096 |
| Other shareholders' equity | 1,894 | 2,548 | 2,592 | 2,587 | 2,589 |
| TOTAL | $419,476 | $436,712 | $182,282 | $194,166 | $209,357 |
| Total Liabilities And Equity | $444,654 | $460,201 | $204,551 | $219,065 | $235,838 |